- Q1 2024 Evotec SE Earnings Call TranscriptMay 22, 2024€9.55 (-0.10%)Earnings
- Full Year 2023 Evotec SE Earnings Call TranscriptApr 24, 2024€9.69 (-31.13%)Earnings
- Evotec SE Corporate Call TranscriptJan 22, 2024
- Evotec SE Capital Markets Day TranscriptNov 15, 2023
- Q3 2023 Evotec SE Earnings Call TranscriptNov 08, 2023€17.55 (+6.57%)Earnings
- Q2 2023 Evotec SE Earnings Call TranscriptAug 29, 2023€21.92 (+6.00%)Earnings
- Evotec SE Corporate Call TranscriptJul 28, 2023
- Evotec SE Capital Markets Day TranscriptJun 05, 2023
- Evotec SE Conference Call TranscriptMay 10, 2023
- Preliminary Q4 2022 Evotec SE Earnings Call TranscriptMar 28, 2023€18.77 (+4.15%)Earnings
- Q3 2022 Evotec SE Earnings Call TranscriptNov 09, 2022€17.26 (-10.81%)Earnings
- Evotec SE Corporate Analyst Meeting TranscriptNov 02, 2022
- Half Year 2022 Evotec SE Earnings Call TranscriptAug 11, 2022€25.34 (+0.48%)Earnings
- Evotec SE and Sernova Corp to Discuss Exclusive Strategic Partnership M&A Call TranscriptMay 17, 2022
- Q1 2022 Evotec SE Earnings Call TranscriptMay 11, 2022€21.28 (-11.28%)Earnings
- Q4 2021 Evotec SE Earnings Call TranscriptApr 12, 2022€24.94 (-7.36%)Earnings
- Evotec SE Capital Markets Day TranscriptMar 02, 2022
- Q3 2021 Evotec SE Earnings Call TranscriptNov 11, 2021€41.81 (+0.97%)Earnings
- Q2 2021 Evotec SE Earnings Call TranscriptAug 11, 2021€38.95 (+2.31%)Earnings
- Q1 2021 Evotec SE Earnings Call TranscriptMay 11, 2021€33.73 (-1.14%)Earnings
- Q4 2020 Evotec SE Earnings Call TranscriptMar 25, 2021€30.19 (-0.25%)Earnings
- Evotec SE Capital Market Day Virtual TranscriptNov 19, 2020
- Q3 2020 Evotec SE Earnings Call TranscriptNov 12, 2020€25.21 (+1.04%)Earnings
- Q2 2020 Evotec SE Earnings Call TranscriptAug 12, 2020€23.01 (-5.50%)Earnings
- Q1 2020 Evotec SE Earnings Call TranscriptMay 14, 2020€22.8 (+0.77%)Earnings
- Q4 2019 Evotec SE Earnings Call TranscriptMar 26, 2020€20.54 (-2.86%)Earnings
- Evotec SE at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Q3 2019 Evotec SE Earnings Call TranscriptNov 12, 2019€19.37 (+0.74%)Earnings
- Q2 2019 Evotec SE Earnings Call TranscriptAug 14, 2019€20.88 (-14.64%)Earnings
- Evotec SE to Provide Information Regarding the Acquisition of Just Biotherapeutics Conference Call TranscriptMay 21, 2019
- Q1 2019 Evotec SE Earnings Call TranscriptMay 14, 2019€22.74 (+4.43%)Earnings
Evotec SE Conference Call Transcript
Good morning, good afternoon. Welcome to Evotec. Today is an important day because it's a significant impact that will happen through the new partnership between Sandoz and Just-Evotec Biologics for the world. Why do I say this? Because when we think about access, then this partnership will make a huge contribution in the future. We have uploaded a presentation for this call that I will host together with Matthias Evers, who was pivotal to make this deal happen. When it comes to the presentation, I would like to guide you to Page #2, which gives you an overview of the tech partnership for biosimilars that we have initiated together with Sandoz.
Before that, let me start by a general definition of what a biosimilar is. The FDA defines a biosimilar is a biological product that is highly similar and has no clinically meaningful differences from an existing FDA-approved reference product. And these are differences when it comes to safety, purity and potency. That's a biosimilar. And I make this definition because typically
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)